Clinical Trial

TILs Therapy for Multiple Primary Early-Stage NSCLC

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This is a single-arm study aimed at evaluating the safety of TILs therapy for multiple primary early-stage NSCLC
Trial Details
NCT Number NCT07498439
Lead Sponsor Tianjin Medical University General Hospital
Conditions Primary Early-stage Non-small Cell Lung Cancer
Enrollment 50 participants
Start Date 2026-03-31
Primary Completion 2028-03-31 (estimated)
Study Completion 2030-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-27